Literature DB >> 10903756

Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-gamma.

C S Subauste1, M Wessendarp.   

Abstract

We studied how the interaction between human dendritic cells (DC) and Toxoplasma gondii influences the generation of cell-mediated immunity against the parasite. We demonstrate that viable, but not killed, tachyzoites of T. gondii altered the phenotype of immature DC. DC infected with viable parasites up-regulated the expression of CD40, CD80, CD86, and HLA-DR and down-regulated expression of CD115. These changes are indicative of DC activation induced by T. gondii. Viable and killed tachyzoites had contrasting effects on cytokine production. DC infected with viable T. gondii rather than DC that phagocytosed killed parasites induced secretion of high amounts of IFN-gamma by T cells from T. gondii-seronegative donors. IFN-gamma production in response to DC infected with viable parasites required CD28 and CD40 ligand (CD40L) signaling. In addition, this IFN-gamma response was dependent in part on IL-12 secretion. Production of IL-12 p70 occurred after interaction between T cells and DC infected with viable T. gondii, but not after incubation of T cells with DC plus killed tachyzoites. IL-12 synthesis was inhibited by blockade of CD40L signaling. IL-12-independent IFN-gamma production required CD80/CD86-CD28 interaction and, to a lesser extent, CD40-CD40L signaling. Taken together, T. gondii-induced activation of human DC is associated with T cell production of IFN-gamma through CD40-CD40L-dependent release of IL-12 and through CD80/CD86-CD28 and CD40-CD40L signaling that mediate IFN-gamma secretion even in the absence of bioactive IL-12.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903756     DOI: 10.4049/jimmunol.165.3.1498

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus.

Authors:  Even Walseng; Kazuyuki Furuta; Romina S Goldszmid; Karis A Weih; Alan Sher; Paul A Roche
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  Toxoplasma gondii- derived profilin triggers human toll-like receptor 5-dependent cytokine production.

Authors:  Rosa Maria Salazar Gonzalez; Hesham Shehata; Michael J O'Connell; Yanfen Yang; Maria E Moreno-Fernandez; Claire A Chougnet; Julio Aliberti
Journal:  J Innate Immun       Date:  2014-05-23       Impact factor: 7.349

3.  Toxoplasma gondii induces B7-2 expression through activation of JNK signal transduction.

Authors:  Pedro Morgado; Yi-Ching Ong; John C Boothroyd; Melissa B Lodoen
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

4.  Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4.

Authors:  Fumie Aosai; Martha S Rodriguez Pena; Hye-Seong Mun; Hao Fang; Tetsuya Mitsunaga; Kazumi Norose; Hyun Kyu Kang; Yoe-Sik Bae; Akihiko Yano
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

5.  Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

Authors:  Ulrike Wille; Eric N Villegas; Linden Craig; Robert Peach; Christopher A Hunter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 6.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

7.  The IL-12 Response of Primary Human Dendritic Cells and Monocytes to Toxoplasma gondii Is Stimulated by Phagocytosis of Live Parasites Rather Than Host Cell Invasion.

Authors:  Kevin W Tosh; Lara Mittereder; Sandra Bonne-Annee; Sara Hieny; Thomas B Nutman; Steven M Singer; Alan Sher; Dragana Jankovic
Journal:  J Immunol       Date:  2015-11-23       Impact factor: 5.422

8.  Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.

Authors:  Jose-Andres C Portillo; Jennifer A Greene; Isaac Schwartz; Maria Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

9.  Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii.

Authors:  Masoumeh Motamedi; Samaneh Arab; Seied Mohammad Moazzeni; Masoomeh Khamis Abadi; Jamshid Hadjati
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

10.  CD40 promotes the development of early diabetic retinopathy in mice.

Authors:  Jose-Andres C Portillo; Jennifer A Greene; Genevieve Okenka; Yanling Miao; Nader Sheibani; Timothy S Kern; Carlos S Subauste
Journal:  Diabetologia       Date:  2014-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.